Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study

Andreozzi, F; Dragani, M; Quivoron, C; Le Bras, F; Assi, T; Danu, A; Belhadj, K; Lazarovici, J; Cotteret, S; Bernard, OA; Ribrag, V; Michot, JM

Andreozzi, F (通讯作者),Gustave Roussy, Dept Innovat Therapeut & Essais Precoces, F-94805 Villejuif, France.;Andreozzi, F (通讯作者),Inst Jules Bordet, Hematol Dept, B-1070 Brussels, Belgium.

CANCERS, 2023; 15 (5):

Abstract

Simple Summary Personalized treatment for patients with relapsed or refractory multiple myeloma (r/r MM) remains an ongoing challenge, and there are n......

Full Text Link